“Cardior Pharmaceuticals is a leading clinical-stage biopharmaceutical company pioneering the discovery and development of RNA-based therapeutics designed to prevent, repair and reverse diseases of the heart. Cardior’s therapeutic approach uses distinctive non-coding RNAs as an innovative platform for addressing the root causes of cardiac dysfunctions. The company aspires to bring transformative therapeutics and diagnostics to patients and thereby make a lasting impact on the treatment of cardiac diseases worldwide.”
Website
Location: Germany, Lower Saxony, Hanover
Employees: 11-50
Total raised: $167.11M
Founded date: 2016
Investors 5
| Date | Name | Website |
| - | Fund+ | fundplus.b... |
| - | Coparion | coparion.v... |
| 03.09.2021 | Hadean Ven... | hadeanvent... |
| 17.07.2021 | High-Tech ... | htgf.de |
| - | Life Scien... | lspvc.com |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 28.08.2021 | Series B | $75.49M | Hadean Ven... |
| 25.08.2021 | Series B | $75.33M | - |
| 11.05.2017 | - | $16.3M | - |
Mentions in press and media 13
| Date | Title | Description | Source |
| 09.04.2024 | Novo Nordisk to acquire Cardior Pharmaceuticals and strength... | Bagsværd, Denmark, and Hannover, Germany, 25 March, 2024 – Novo Nordisk and Cardior Pharmaceuticals ... | fundplus.b... |
| 27.07.2022 | Cardior Announces First Patient Dosed in Phase 2 Study | Hanover, Germany, July 20, 2022 – Cardior Pharmaceuticals, a clinical-stage biotech company develop... | hadeanvent... |
| 22.02.2022 | TargED Biopharmaceuticals raises EUR 39 Million in Series A ... | TargED Biopharmaceuticals raises EUR 39 Million in Series A financing to bring groundbreaking throm... | hadeanvent... |
| 31.08.2021 | Digital health news, funding roundup in the prior week; Augu... | Headspace's resilience brand and Ginger's clinical heft create mental health powerhouse Bambi Franci... | vator.tv/n... |
| 26.08.2021 | The CEO of one-time unicorn HeadSpin gets arrested for alleg... | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign ... | fortune.co... |
| 26.08.2021 | Cardior Raises €64 M Series B to Advance Clinical Pipeline o... | Oversubscribed round enables late-stage clinical development of lead candidate, a micro-RNA-132 inh... | hadeanvent... |
| 26.08.2021 | The CEO of one-time unicorn HeadSpin gets arrested for alleg... | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign ... | fortune.co... |
| 26.08.2021 | Biopharma startup Cardior lands €64M Series B | Germany-based Cardior Pharmaceuticals has secured €64 million in a round led by Inkef Capital, with ... | pitchbook.... |
| 25.08.2021 | Cardior Raises €64M in Series B Funding | Cardior Pharmaceuticals, a Hanover, Germany-based clinical-stage biotech company developing non-codi... | finsmes.co... |
| 25.08.2021 | Bristol-backed Cardior gets $75M to run midphase antisense h... | The heart failure field has finally started to see progress in recent years, as drugs such as Novart... | fiercebiot... |
Show more